According to Cogent Biosciences's latest financial reports the company's current EPS (TTM) is -$3.18. In 2022 the company made an earnings per share (EPS) of -$3.33 a decrease over its 2021 EPS that were of -$2.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.16 | -5.2% |
2022 | -$3.33 | 34.71% |
2021 | -$2.47 | -85.89% |
2020 | -$17.51 | 206.9% |
2019 | -$5.71 | -33.54% |
2018 | -$8.59 | 53.17% |
2017 | -$5.61 |